(Q51076744)

English

A randomized investigator-blind parallel-group study to assess efficacy and safety of azelaic acid 15% gel vs. adapalene 0.1% gel in the treatment and maintenance treatment of female adult acne.

scientific article published on 14 November 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/25399481

A randomized investigator-blind parallel-group study to assess efficacy and safety of azelaic acid 15% gel vs. adapalene 0.1% gel in the treatment and maintenance treatment of female adult acne. (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/25399481

author name string

A Thielitz

1

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/25399481

A Lux

2

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/25399481

A Wiede

3

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/25399481

S Kropf

4

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/25399481

E Papakonstantinou

5

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/25399481

H Gollnick

6

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/25399481

publication date

14 November 2014

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/25399481

Journal of the European Academy of Dermatology and Venereology

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/25399481

29

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/25399481

4

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/25399481

789-796

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/25399481

Can we define acne as a chronic disease? If so, how and when?

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12823

21 January 2018

Female acne - a different subtype of teenager acne?

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12823

21 January 2018

New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12823

21 January 2018

The prevalence of acne in adults 20 years and older

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12823

21 January 2018

An epidemiological study of acne in female adults: results of a survey conducted in France

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12823

21 January 2018

Adult female acne: a new paradigm

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12823

21 January 2018

Management of acne in women over 25 years of age

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12823

21 January 2018

Topical retinoids in acne--an evidence-based overview

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12823

21 January 2018

Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12823

21 January 2018

Azelaic acid 15% gel in the treatment of acne vulgaris. Combined results of two double-blind clinical comparative studies

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12823

21 January 2018

Interest of the association retinaldehyde/glycolic acid in adult acne

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12823

21 January 2018

Isotretinoin 5 mg daily for low-grade adult acne vulgaris--a placebo-controlled, randomized double-blind study

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12823

21 January 2018

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12823

21 January 2018

Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use.

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12823

21 January 2018

Acne vulgaris in the elderly: the response to low-dose isotretinoin

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12823

21 January 2018

Azelaic acid modulates the inflammatory response in normal human keratinocytes through PPARgamma activation

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12823

21 January 2018

Interleukin-1β interferes with epidermal homeostasis through induction of insulin resistance: implications for psoriasis pathogenesis.

1 reference

https://api.crossref.org/works/10.1111%2FJDV.12823

21 January 2018

Identifiers

10.1111/JDV.12823

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/25399481

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

28 March 2018

http://europepmc.org/abstract/MED/25399481

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51076744&oldid=842177410"